Claims That Pharma Firm's Board Downplayed Risk of Liver Drug to Proceed in Delaware

Delaware Business Court Insider

Jan 29, 2021

The case was moved from New York under a clause in Intercept's bylaws specifying derivative actions against the company are to be addressed in a state or federal court in Delaware,…